PubRank

Mario Stevenson

Author PubWeight™ 73.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Modulation of HIV-1 replication by RNA interference. Nature 2002 5.90
2 Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 2012 5.52
3 HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med 2010 5.36
4 Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science 2004 5.31
5 Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 2014 2.95
6 HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 2003 2.90
7 Small-molecule inhibition of HIV-1 Vif. Nat Biotechnol 2008 2.83
8 Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog 2008 2.72
9 A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 2009 2.34
10 Macrophages archive HIV-1 virions for dissemination in trans. EMBO J 2005 2.27
11 The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature 2006 2.02
12 In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA. J Virol 2005 1.80
13 Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 2007 1.61
14 Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol 2004 1.52
15 Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study. Antivir Ther 2011 1.41
16 Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure. PLoS Pathog 2011 1.32
17 Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 2008 1.31
18 Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A 2002 1.27
19 Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J Virol 2004 1.26
20 Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med 2002 1.23
21 Deep molecular characterization of HIV-1 dynamics under suppressive HAART. PLoS Pathog 2011 1.21
22 Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. J Leukoc Biol 2006 1.19
23 In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio 2013 1.18
24 Overcoming pharmacologic sanctuaries. Curr Opin HIV AIDS 2013 1.17
25 Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J Virol 2006 1.14
26 HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions. J Leukoc Biol 2003 1.13
27 Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages. J Virol 2005 1.06
28 Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. Retrovirology 2004 1.05
29 The search for a cure for persistent HIV reservoirs. AIDS Rev 2011 0.98
30 The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages. J Virol 2012 0.97
31 Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication. Chembiochem 2009 0.95
32 HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children. J Immunol 2003 0.89
33 HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro. AIDS Res Hum Retroviruses 2012 0.89
34 A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles. J Virol 2011 0.89
35 Synthesis and structure-activity relationship studies of HIV-1 virion infectivity factor (Vif) inhibitors that block viral replication. ChemMedChem 2012 0.87
36 Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification. J Acquir Immune Defic Syndr 2013 0.86
37 Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus. J Virol 2010 0.81
38 A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages. J Virol 2010 0.80
39 Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir. AIDS Res Hum Retroviruses 2015 0.77
40 TRIMming HIV-1's mainsail. Nat Immunol 2004 0.76
41 Tat's seductive side. Nat Med 2003 0.75
42 Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure. AIDS Res Ther 2012 0.75
43 Zika Virus: Obstetric and Pediatric Anesthesia Considerations. Anesth Analg 2017 0.75
44 Unsung hero Robert C. Gallo. Science 2009 0.75
45 A plea for justice for jailed medical workers. Science 2006 0.75